Why a tiny genetic error causes the fatal buildup of toxins in the brain
In short: Tay-Sachs is a rare, inherited disorder where a missing enzyme allows toxic fatty substances to accumulate in the brain. This buildup destroys nerve cells, leading to severe neurological decline. While the infantile form is devastating, genetic testing has successfully reduced the incidence of this condition in high-risk communities worldwide.
Tay-Sachs disease is a lysosomal storage disorder caused by variants in the HEXA gene. This gene provides instructions for creating the alpha subunit of beta-hexosaminidase A, an enzyme located in cellular recycling centers called lysosomes. Under normal conditions, this enzyme breaks down a fatty substance known as GM2 ganglioside. When HEXA variants eliminate or severely reduce enzyme function, GM2 ganglioside accumulates to toxic levels, specifically within neurons in the central nervous system.
The disease is inherited in an autosomal recessive pattern, meaning an individual must inherit a variant copy of the HEXA gene from both parents to develop the condition. Parents who carry only one variant copy typically show no symptoms because their bodies rely on the single working gene. If two carriers have a child, there is a 25% chance the child will inherit both variants and develop the disease, a 50% chance they will be a carrier, and a 25% chance they will inherit no variants at all.
The severity of the disease correlates with the amount of residual enzyme activity. The infantile form, which is the most common and severe, typically appears between 3 and 6 months of age as infants lose previously acquired skills like sitting or crawling. Characteristic signs include an exaggerated startle reaction and a cherry-red spot in the eye. Conversely, juvenile and late-onset forms are rarer and often milder, with symptoms appearing later in childhood or adulthood. While infantile Tay-Sachs is fatal in early childhood, often due to pneumonia, late-onset forms may not impact life expectancy.
The condition is more prevalent in specific populations, including Ashkenazi Jewish, French-Canadian, Cajun, and Old Order Amish communities. Increased education and widespread genetic testing have significantly lowered the incidence of Tay-Sachs within these groups. Because the disease is rare in the general population, these targeted efforts remain a primary tool for prevention.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Tay-Sachs disease: MedlinePlus Genetics
- Also: Tay-Sachs Disease: What Is It?
- Also: Tay-Sachs disease - Symptoms and causes
- Also: Tay–Sachs disease
To cite this card, link to https://intellectplus.co.uk/app/technology-tay-sachs-disease.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health · Latest · A–Z · All topics